Conmed Corp(CNMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 24.75 | EPS (ttm) | 1.85 | Insider Own | 0.39% | Shs Outstand | 30.0M | Perf Week | -2.87% |
| Market Cap | 1.37B | Forward P/E | 9.57 | EPS next Y | 5.42% | Insider Trans | - | Shs Float | 29.8M | Perf Month | -1.99% |
| Enterprise Value | 2.17B | PEG | 1.73 | EPS next Q | 1.27 | Inst Own | 114.13% | Short Float | 6.41% | Perf Quarter | -2.6% |
| Income | 0.06B | P/S | 1 | EPS this Y | -1.18% | Inst Trans | 0.37% | Short Ratio | 4.8 | Perf Half Y | 27.25% |
| Sales | 1.37B | P/B | 1.32 | EPS next 5Y | 5.53% | ROA | 2.44% | Short Interest | 1.91M | Perf YTD | 12.71% |
| Book/sh | 34.73 | P/C | 36.71 | EPS past 3/5Y | - 36.14% | ROE | 5.53% | 52W High | -14.72% ($53.66) | Perf Year | -3.3% |
| Cash/sh | 1.25 | P/FCF | 10.19 | Sales past 3/5Y | 10.08% 9.82% | ROIC | 3.33% | 52W Low | 45.55% ($31.44) | Perf 3Y | -51.81% |
| Dividend Est. | - | EV/EBITDA | 10.49 | EPS Y/Y TTM | -48.06% | Gross Margin | 53.68% | Volatility(W/M) | 4.4% 3.81% | Perf 5Y | -68.59% |
| Dividend TTM | - | EV/Sales | 1.58 | Sales Y/Y TTM | 3.86% | Oper. Margin | 10.95% | ATR (14) | 1.8 | Perf 10Y | 14.4% |
| Dividend Ex-Date | 2025/9/15 | Quick Ratio | 0.69 | EPS Q/Q | 11.05% | Profit Margin | 4.11% | RSI (14) | 45.94 | Recom | 3.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.48 | Sales Q/Q | 0.21% | SMA20 | -1.34% ($46.38) | Beta | 0.9 | Target Price | $45.5 |
| Payout | 39.72% | Debt/Eq | 0.8 | Earnings | 2026/10/28 | SMA50 | -3.31% ($47.33) | Rel Volume | 1.53 | Prev Close | $47.2 |
| Employees | 3900 | LT Debt/Eq | 0.63 | EPS/Sales Surpr. | 3.7% -0.22% | SMA200 | 10.62% ($41.37) | Avg Volume(3M) | 0.40M | Price | $45.76 |
| IPO | 1987/7/23 | Option/Short | Yes/Yes | Trades | 6956 | Volume | 610,215 | Change | -3.05% |
🔬 Conmed (CNMD) is a U.S. global medical device company specializing in orthopedic and general surgery fields. It supplies surgeons with minimally invasive surgical equipment such as arthroscopes, electrosurgical devices, and endoscopes, along with disposable consumables, running a business model that combines equipment sales with recurring consumable revenue. Hospitals and surgical centers are its core customers, and its products are distributed worldwide.
Over the past 1 year, roughly in the middle
15% below its 1-year high.
Traded more than usual. That is 153% of its average volume.
CNMD makes money exceptionally well
Of every $100 in sales, $10.95 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -1.2% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,475. Peers typically go for $2,796. It is about in line with its own 4-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -68.6%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 114.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #34 of 142 in the industry
Based on market cap of $1B.
FAQ
What kind of company is CNMD?
CNMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of CNMD?
The market cap of CNMD is approximately $1.4B, ranking 2,357 within its sector.
What is the P/E ratio of CNMD?
CNMD has a P/E ratio of approximately 24.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CNMD?
CNMD has recorded a 52-week high of $53.66 and a low of $31.44.
